Connection

David Ho to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications David Ho has written about Antibodies, Monoclonal.
David Ho
Connection Strength
0.481
Antibodies, Monoclonal
  1. Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1. Proc Natl Acad Sci U S A. 2013 Aug 13; 110(33):13540-5.
    View in: PubMed
    Score: 0.133
  2. Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies. Structure. 2021 07 01; 29(7):655-663.e4.
    View in: PubMed
    Score: 0.057
  3. Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell Host Microbe. 2021 05 12; 29(5):747-751.e4.
    View in: PubMed
    Score: 0.057
  4. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature. 2021 05; 593(7857):130-135.
    View in: PubMed
    Score: 0.056
  5. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020 08; 584(7821):450-456.
    View in: PubMed
    Score: 0.054
  6. The Miami Monkey: A Sunny Alternative to the Berlin Patient. Immunity. 2019 03 19; 50(3):537-539.
    View in: PubMed
    Score: 0.049
  7. Engineering multi-specific antibodies against HIV-1. Retrovirology. 2018 08 29; 15(1):60.
    View in: PubMed
    Score: 0.047
  8. In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies. Emerg Microbes Infect. 2020 Dec; 9(1):1523-1533.
    View in: PubMed
    Score: 0.014
  9. Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles. Cell Host Microbe. 2020 12 09; 28(6):880-891.e8.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.